147 related articles for article (PubMed ID: 33371687)
41. Targeted MMP-2 responsive chimeric polymersomes for therapy against colorectal cancer.
Ramezani P; Abnous K; Taghdisi SM; Zahiri M; Ramezani M; Alibolandi M
Colloids Surf B Biointerfaces; 2020 Sep; 193():111135. PubMed ID: 32447200
[TBL] [Abstract][Full Text] [Related]
42. PD-L1-targeted microbubbles loaded with docetaxel produce a synergistic effect for the treatment of lung cancer under ultrasound irradiation.
Li T; Hu Z; Wang C; Yang J; Zeng C; Fan R; Guo J
Biomater Sci; 2020 Mar; 8(5):1418-1430. PubMed ID: 31942578
[TBL] [Abstract][Full Text] [Related]
43. Mitochondria-targeted tetrahedral DNA nanostructures for doxorubicin delivery and enhancement of apoptosis.
Yan J; Chen J; Zhang N; Yang Y; Zhu W; Li L; He B
J Mater Chem B; 2020 Jan; 8(3):492-503. PubMed ID: 31840727
[TBL] [Abstract][Full Text] [Related]
44. Apatinib sensitizes chemoresistant NSCLC cells to doxetaxel via regulating autophagy and enhances the therapeutic efficacy in advanced and refractory/recurrent NSCLC.
Hu R; Li T; Hui K; Chen Z; Wang N; Wu X; Ge L; Zhou L
Mol Med Rep; 2020 Nov; 22(5):3935-3943. PubMed ID: 32901884
[TBL] [Abstract][Full Text] [Related]
45. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
46. Simultaneous Targeting of Differentiated Breast Cancer Cells and Breast Cancer Stem Cells by Combination of Docetaxel- and Sulforaphane-Loaded Self-Assembled Poly(D, L-lactide-co-glycolide)/Hyaluronic Acid Block Copolymer-Based Nanoparticles.
Huang J; Tao C; Yu Y; Yu F; Zhang H; Gao J; Wang D; Chen Y; Gao J; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Zou H; Xu H; Lu Y; Zhong Y
J Biomed Nanotechnol; 2016 Jul; 12(7):1463-77. PubMed ID: 29337484
[TBL] [Abstract][Full Text] [Related]
47. Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1.
Sutter AP; Maaser K; Grabowski P; Bradacs G; Vormbrock K; Höpfner M; Krahn A; Heine B; Stein H; Somasundaram R; Schuppan D; Zeitz M; Scherübl H
J Hepatol; 2004 Nov; 41(5):799-807. PubMed ID: 15519653
[TBL] [Abstract][Full Text] [Related]
48. Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and Mitoxantrone.
Kalantzis ED; Scorilas A; Vassilacopoulou D
Curr Pharm Biotechnol; 2018; 19(13):1087-1096. PubMed ID: 30417785
[TBL] [Abstract][Full Text] [Related]
49. Teng-Long-Bu-Zhong-Tang, a Chinese herbal formula, enhances anticancer effects of 5--Fluorouracil in CT26 colon carcinoma.
Deng S; Hu B; An HM; Du Q; Xu L; Shen KP; Shi XF; Wei MM; Wu Y
BMC Complement Altern Med; 2013 Jun; 13():128. PubMed ID: 23758730
[TBL] [Abstract][Full Text] [Related]
50. Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
Kroon J; Puhr M; Buijs JT; van der Horst G; Hemmer DM; Marijt KA; Hwang MS; Masood M; Grimm S; Storm G; Metselaar JM; Meijer OC; Culig Z; van der Pluijm G
Endocr Relat Cancer; 2016 Jan; 23(1):35-45. PubMed ID: 26483423
[TBL] [Abstract][Full Text] [Related]
51. Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB.
Lee SY; Cho JS; Yuk DY; Moon DC; Jung JK; Yoo HS; Lee YM; Han SB; Oh KW; Hong JT
J Pharmacol Sci; 2009 Oct; 111(2):124-36. PubMed ID: 19834284
[TBL] [Abstract][Full Text] [Related]
52. Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice.
Enteshari S; Varshosaz J; Minayian M; Hassanzadeh F
Invest New Drugs; 2018 Apr; 36(2):206-216. PubMed ID: 29177974
[TBL] [Abstract][Full Text] [Related]
53. Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles.
Kumari M; Purohit MP; Patnaik S; Shukla Y; Kumar P; Gupta KC
Eur J Pharm Biopharm; 2018 Sep; 130():185-199. PubMed ID: 29969665
[TBL] [Abstract][Full Text] [Related]
54. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the Synergism Mechanism of Tamoxifen and Docetaxel by Nanoparticles.
Zhu Z; Pan H; Li Y; Pan W
Anticancer Agents Med Chem; 2019; 19(16):1991-2000. PubMed ID: 31267877
[TBL] [Abstract][Full Text] [Related]
56. Safflower seed extract synergizes the therapeutic effect of cisplatin and reduces cisplatin-induced nephrotoxicity in human colorectal carcinoma RKO cells and RKO-transplanted mice.
Park CH; Kim MJ; Yang CY; Yokozawa T; Shin YS
Drug Discov Ther; 2019; 13(6):328-334. PubMed ID: 31956231
[TBL] [Abstract][Full Text] [Related]
57. Oestrogen receptor-mediated liposomal drug delivery for treating melanoma.
Ganguly A; Rachamalla HKR; Bhattacharya D; Bhamidipati K; Pal A; Gora Ravuri H; Chakravarty S; Adhikari SS; Banerjee R
J Drug Target; 2018; 26(5-6):481-493. PubMed ID: 29376759
[TBL] [Abstract][Full Text] [Related]
58. Atractylenolide III Enhances the Anti-Neoplastic Efficacy of Docetaxel in Gastric Cancer Cell by Inhibiting Fibroblast Growth Factor Receptors 1, -2, and -4 Expression.
Ji Y; Kang Z; Kang N; Zhao Y; Guo Q; Chen Y
J Environ Pathol Toxicol Oncol; 2019; 38(3):217-227. PubMed ID: 31679309
[TBL] [Abstract][Full Text] [Related]
59. CD44-targeted nanoparticles for co-delivery of docetaxel and an Akt inhibitor against colorectal cancer.
Gonzalez-Valdivieso J; Vallejo R; Rodriguez-Rojo S; Santos M; Schneider J; Arias FJ; Girotti A
Biomater Adv; 2023 Nov; 154():213595. PubMed ID: 37639856
[TBL] [Abstract][Full Text] [Related]
60. Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
Yemelyanov A; Bhalla P; Yang X; Ugolkov A; Iwadate K; Karseladze A; Budunova I
Cell Cycle; 2012 Jan; 11(2):395-406. PubMed ID: 22223138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
